Check your eligibility now & get in touch with a study center

CHECK ELIGIBILITY

Find a participating research site

If you are interested in taking part in this study, begin typing your post code below and then select from the dropdown list. The map will update with sites within the distance you select with a list of locations below.

Please note the map below only lists study sites that are accepting online referrals. If you cannot find a site in your area please check back again as study sites can be added to the study on an ongoing basis.


Find a site near you

More about study participation.

Participation in the study lasts approximately six years (and may be shorter or longer for certain participants). This includes: 

a screening period of approximately 35 days,
an initial 24-week treatment period (which may be extended if certain criteria are met and if you continue to benefit from the treatment), and
a follow-up period where you will be contacted approximately every 12 weeks to ask how you are doing (follow up on progress). 
The study drug being used in the COMMANDS Trial is is a protein that aims to help increase the production of red blood cells in bone marrow. The study drug will be administered as an injection every three weeks during the treatment period.

The COMMANDS Trial is sponsored by Celgene, A Bristol-Myers Squibb Company.

At Celgene, we recognize the importance of, and are fully committed to protecting the privacy of information related to all individuals with whom we interact. Click privacy policy and/or terms of use to learn more.

© 2020 Celgene Corporation, A Bristol-Myers Squibb Company. All Rights Reserved